Hawaii 2022 Regular Session

Hawaii Senate Bill SR28 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	THE SENATE S.R. NO. 28 THIRTY-FIRST LEGISLATURE, 2022 ~~S.D. 1~~ STATE OF HAWAII SENATE RESOLUTION REQUESTING THE BLOOD BANK OF HAWAII TO IMMEDIATELY ADOPT THE FOOD AND DRUG ADMINISTRATION'S UPDATED GUIDANCE, WHICH SHORTENS OR ELIMINATES THE DEFERRAL PERIOD FOR CERTAIN BLOOD DONORS.
	1	+	THE SENATE S.R. NO. 28 THIRTY-FIRST LEGISLATURE, 2022 STATE OF HAWAII SENATE RESOLUTION requesting the Blood Bank of Hawaii to immediately adopt the Food and Drug Administration's updated guidance WHICH shortenS or eliminatES the deferral period for certain blood donors.
2	2
3	3		THE SENATE S.R. NO. 28
4		-	THIRTY-FIRST LEGISLATURE, 2022 ~~S.D. 1~~
	4	+	THIRTY-FIRST LEGISLATURE, 2022
5	5		STATE OF HAWAII
6	6
7	7		THE SENATE
8	8
9	9		S.R. NO.
10	10
11	11		28
12	12
13	13		THIRTY-FIRST LEGISLATURE, 2022
14	14
15		-	~~S.D. 1~~
	15	+
16	16
17	17		STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29		SENATE RESOLUTION
30	30
31	31
32	32
33	33
34	34
35		-	REQUESTING THE BLOOD BANK OF HAWAII TO IMMEDIATELY ADOPT THE FOOD AND DRUG ADMINISTRATION'S UPDATED GUIDANCE, WHICH SHORTENS OR ELIMINATES THE DEFERRAL PERIOD FOR CERTAIN BLOOD DONORS.
	35	+	requesting the Blood Bank of Hawaii to immediately adopt the Food and Drug Administration's updated guidance WHICH shortenS or eliminatES the deferral period for certain blood donors.
36	36
37	37
38	38
39	39
40	40
41		-	WHEREAS, due to fears of the coronavirus disease 2019 (COVID-19) pandemic, blood bank donations decreased substantially in 2021, resulting in an historic blood inventory shortage in the State; and WHEREAS, the Blood Bank of Hawaii is the sole provider of blood to the eighteen civilian hospitals in the State and one on Guam; and WHEREAS, regular blood inventory maintenance requires one hundred and fifty blood donors every day; however, because of the State's blood shortage, the Blood Bank of Hawaii has ~~not~~ been ~~able~~ to ~~adequately supply~~ the State's hospitals, leaving them with between sixty and eighty percent of the normal supply; and WHEREAS, the blood supply shortage is a health crisis and poses a significant risk to those who suffer medical emergencies that require blood transfusions; and WHEREAS, the federal Food and Drug Administration (FDA) is the government agency that determines blood donor eligibility requirements; and WHEREAS, due to the shortage of blood donations nationally during the COVID-19 pandemic, the FDA revised its blood donor eligibility guidance for several categories of blood donors, which shortened or eliminated completely the deferral period, or the amount of time these donors must wait before donating blood; and WHEREAS, for male donors who would have been deferred for having sex with another man, the FDA changed the recommended deferral period from twelve months to three months since the donor's last sexual encounter; and WHEREAS, for female donors who would have been deferred for having sex with a man who had sex with another man, the FDA changed the recommended deferral period from twelve months to three months since the donor's last sexual encounter; and WHEREAS, for those donors who would have been deferred for tattoos or piercings, the FDA changed the recommended deferral period from twelve months to three months from receiving the tattoo or piercing; and WHEREAS, for those donors who would have been deferred for traveling to malaria-endemic areas (and are residents of malaria non-endemic countries), the FDA changed the recommended deferral period from twelve months to three months, or no deferral period in certain cases; and WHEREAS, for those donors would have been deferred for spending time in certain European countries or on military bases in Europe who were previously considered to have been exposed to a potential risk of transmission of Creutzfeldt-Jakob Disease or Variant Creutzfeldt-Jakob Disease, the FDA eliminated its recommended deferrals; and WHEREAS, the FDA's updated guidance relating to blood donation has been in place since at least August 2020; and WHEREAS, the Blood Bank of Hawaii states on its website that it "strictly adheres to FDA regulations"; and WHEREAS, the Blood Bank of Hawaii has yet to adopt any of the FDA's updated guidance; now, therefore, BE IT RESOLVED by the Senate of the Thirty-first Legislature of the State of Hawaii, Regular Session of 2022, that the Blood Bank of Hawaii is requested to immediately adopt the Food and Drug Administration's updated guidance, shortening or eliminating the deferral period for certain blood donors; and BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Director of Health and Chair of the Blood Bank of Hawaii. Report Title: Blood bank; donors; blood disease
	41	+	WHEREAS, due to fears of the coronavirus disease 2019 (COVID-19) pandemic, blood bank donations decreased substantially in 2021, resulting in an historic blood inventory shortage in the State; and WHEREAS, the Blood Bank of Hawaii is the sole provider of blood to the eighteen civilian hospitals in the State and one on Guam; and WHEREAS, regular blood inventory maintenance requires one hundred and fifty blood donors every day; however, because of the State's blood shortage, the Blood Bank of Hawaii has been forced to undersupply the State's hospitals, leaving them with between sixty and eighty percent of the normal supply; and WHEREAS, the blood supply shortage is a health crisis and poses a significant risk to those who suffer medical emergencies that require blood transfusions; and WHEREAS, the federal Food and Drug Administration (FDA) is the government agency that determines blood donor eligibility requirements; and WHEREAS, due to the shortage of blood donations nationally during the COVID-19 pandemic, the FDA revised its blood donor eligibility guidance for several categories of blood donors, which shortened or eliminated completely the deferral period, or the amount of time these donors must wait before donating blood; and WHEREAS, for male donors who would have been deferred for having sex with another man, the FDA changed the recommended deferral period from twelve months to three months since the donor's last sexual encounter; and WHEREAS, for female donors who would have been deferred for having sex with a man who had sex with another man, the FDA changed the recommended deferral period from twelve months to three months since the donor's last sexual encounter; and WHEREAS, for those donors who would have been deferred for tattoos or piercings, the FDA changed the recommended deferral period from twelve months to three months from receiving the tattoo or piercing; and WHEREAS, for those donors who would have been deferred for traveling to malaria-endemic areas (and are residents of malaria non-endemic countries), the FDA changed the recommended deferral period from twelve months to three months, or no deferral period in certain cases; and WHEREAS, for those donors would have been deferred for spending time in certain European countries or on military bases in Europe who were previously considered to have been exposed to a potential risk of transmission of Creutzfeldt-Jakob Disease or Variant Creutzfeldt-Jakob Disease, the FDA eliminated its recommended deferrals; and WHEREAS, the FDA's updated guidance relating to blood donation has been in place since at least August 2020; and WHEREAS, the Blood Bank of Hawaii states on its website that it "strictly adheres to FDA regulations"; and WHEREAS, the Blood Bank of Hawaii has yet to adopt any of the FDA's updated guidance; now, therefore, BE IT RESOLVED by the Senate of the Thirty-first Legislature of the State of Hawaii, Regular Session of 2022, that the Blood Bank of Hawaii is requested to immediately adopt the Food and Drug Administration's updated guidance, shortening or eliminating the deferral period for certain blood donors; and BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Director of Health and Chair of the Blood Bank of Hawaii. OFFERED BY: _____________________________ Report Title: Blood bank; donors; blood disease
42	42
43	43		WHEREAS, due to fears of the coronavirus disease 2019 (COVID-19) pandemic, blood bank donations decreased substantially in 2021, resulting in an historic blood inventory shortage in the State; and
44	44
45	45
46	46
47	47		WHEREAS, the Blood Bank of Hawaii is the sole provider of blood to the eighteen civilian hospitals in the State and one on Guam; and
48	48
49	49
50	50
51		-	WHEREAS, regular blood inventory maintenance requires one hundred and fifty blood donors every day; however, because of the State's blood shortage, the Blood Bank of Hawaii has ~~not~~ been ~~able~~ to ~~adequately supply~~ the State's hospitals, leaving them with between sixty and eighty percent of the normal supply; and
	51	+	WHEREAS, regular blood inventory maintenance requires one hundred and fifty blood donors every day; however, because of the State's blood shortage, the Blood Bank of Hawaii has been forced to undersupply the State's hospitals, leaving them with between sixty and eighty percent of the normal supply; and
52	52
53	53
54	54
55	55		WHEREAS, the blood supply shortage is a health crisis and poses a significant risk to those who suffer medical emergencies that require blood transfusions; and
56	56
57	57
58	58
59	59		WHEREAS, the federal Food and Drug Administration (FDA) is the government agency that determines blood donor eligibility requirements; and
60	60
61	61
62	62
63	63		WHEREAS, due to the shortage of blood donations nationally during the COVID-19 pandemic, the FDA revised its blood donor eligibility guidance for several categories of blood donors, which shortened or eliminated completely the deferral period, or the amount of time these donors must wait before donating blood; and
64	64
65	65
66	66
67	67		WHEREAS, for male donors who would have been deferred for having sex with another man, the FDA changed the recommended deferral period from twelve months to three months since the donor's last sexual encounter; and
68	68
69	69
70	70
71	71		WHEREAS, for female donors who would have been deferred for having sex with a man who had sex with another man, the FDA changed the recommended deferral period from twelve months to three months since the donor's last sexual encounter; and
72	72
73	73
74	74
75	75		WHEREAS, for those donors who would have been deferred for tattoos or piercings, the FDA changed the recommended deferral period from twelve months to three months from receiving the tattoo or piercing; and
76	76
77	77
78	78
79	79		WHEREAS, for those donors who would have been deferred for traveling to malaria-endemic areas (and are residents of malaria non-endemic countries), the FDA changed the recommended deferral period from twelve months to three months, or no deferral period in certain cases; and
80	80
81	81
82	82
83	83		WHEREAS, for those donors would have been deferred for spending time in certain European countries or on military bases in Europe who were previously considered to have been exposed to a potential risk of transmission of Creutzfeldt-Jakob Disease or Variant Creutzfeldt-Jakob Disease, the FDA eliminated its recommended deferrals; and
84	84
85	85
86	86
87	87		WHEREAS, the FDA's updated guidance relating to blood donation has been in place since at least August 2020; and
88	88
89	89
90	90
91	91		WHEREAS, the Blood Bank of Hawaii states on its website that it "strictly adheres to FDA regulations"; and
92	92
93	93
94	94
95	95		WHEREAS, the Blood Bank of Hawaii has yet to adopt any of the FDA's updated guidance; now, therefore,
96	96
97	97
98	98
99	99		BE IT RESOLVED by the Senate of the Thirty-first Legislature of the State of Hawaii, Regular Session of 2022, that the Blood Bank of Hawaii is requested to immediately adopt the Food and Drug Administration's updated guidance, shortening or eliminating the deferral period for certain blood donors; and
100	100
101	101
102	102
103	103		BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Director of Health and Chair of the Blood Bank of Hawaii.
104	104
	105	+
	106	+
	107	+
	108	+
	109	+
	110	+
	111	+	OFFERED BY: _____________________________
	112	+
	113	+
	114	+
	115	+	OFFERED BY:
	116	+
	117	+	_____________________________
	118	+
	119	+
	120	+
	121	+
	122	+
105	123		Report Title:
106	124
107	125		Blood bank; donors; blood disease